Barbiturates are a class of sedative drugs that slow brain activity by enhancing the effects of a chemical messenger called GABA. While dozens of barbiturates have been developed since the early 1900s, only a handful remain in medical use today. The most commonly encountered include phenobarbital, pentobarbital, secobarbital, amobarbital, and butalbital.
Barbiturates Still Used in Medicine
Phenobarbital is the most widely prescribed barbiturate. It’s primarily used to treat seizures that don’t respond to first-line anti-seizure medications. Of all the barbiturates, phenobarbital has the longest track record in clinical use and remains on the World Health Organization’s list of essential medicines.
Butalbital is found in combination headache medications sold under the brand name Fiorinal (and similar products). It’s paired with caffeine and a pain reliever to treat tension headaches and migraines. This is one of the few barbiturates people encounter in an outpatient pharmacy setting.
Pentobarbital (brand name Nembutal) was once common for sedation and insomnia but is now rarely used in humans. It still plays a major role in veterinary medicine, where it’s the standard drug for animal euthanasia. In a clinical setting, pentobarbital is occasionally used to manage dangerously high pressure inside the skull.
Secobarbital (brand name Seconal) is a short-acting barbiturate historically prescribed for severe insomnia. Its use has dropped dramatically since the introduction of safer sleep medications, though it remains available.
Amobarbital is another short-to-intermediate acting barbiturate. It sees limited use today, mostly in specialized hospital settings.
Thiopental (brand name Pentothal) was the classic “truth serum” drug and a mainstay of anesthesia induction for decades. It works within seconds when given intravenously. While largely replaced by newer anesthetics, it still appears in some medical protocols.
How Barbiturates Are Classified
Barbiturates are grouped by how quickly they take effect and how long they last. This matters because the category determines what each drug is used for.
- Ultra-short acting (minutes): Thiopental and methohexital. These kick in almost immediately and wear off fast, making them useful for anesthesia induction.
- Short acting (3 to 4 hours): Secobarbital and pentobarbital. Originally prescribed for insomnia because their effects don’t linger into the next day.
- Intermediate acting (6 to 8 hours): Amobarbital and butalbital. Used for sedation and headache treatment.
- Long acting (10 to 12 hours or more): Phenobarbital. Its extended duration makes it effective for seizure prevention, where you need steady drug levels around the clock.
How They Work in the Brain
Barbiturates target a receptor in the brain called GABA-A, which acts as the nervous system’s main braking mechanism. When GABA (a naturally occurring chemical) binds to this receptor, it opens a channel that lets chloride ions flow into nerve cells, calming electrical activity. Barbiturates bind to a different spot on the same receptor and amplify this calming effect.
What makes barbiturates particularly powerful, and dangerous, is that at higher doses they can directly open these chloride channels on their own, without GABA present at all. This is a key difference from benzodiazepines like diazepam or alprazolam, which can only boost GABA’s natural activity but can’t activate the receptor independently. That distinction is why barbiturate overdoses can suppress breathing to a fatal degree more easily than benzodiazepine overdoses.
Controlled Substance Scheduling
All barbiturates are controlled substances under federal law, but they fall into different schedules depending on their abuse potential. Amobarbital, pentobarbital, and secobarbital are classified as Schedule II, the same category as oxycodone and fentanyl. This reflects their high potential for dependence. Butalbital and phenobarbital are placed in Schedule IV, indicating a lower (but still real) risk of abuse.
Why They Fell Out of Favor
Barbiturates dominated prescribing for anxiety, insomnia, and sedation from the 1920s through the 1960s. Their decline came down to one core problem: the gap between a therapeutic dose and a lethal dose is dangerously small. A person taking just a few extra pills could slip into life-threatening respiratory depression. Benzodiazepines, introduced in the 1960s, offered similar sedation with a much wider safety margin and gradually replaced barbiturates for most uses.
Chronic barbiturate use also causes the body to ramp up its liver enzymes, particularly a family of enzymes involved in drug metabolism. Phenobarbital, for instance, significantly increases the activity of several enzyme groups that break down medications. The practical result is that barbiturates can reduce the effectiveness of many other drugs a person takes, including blood thinners, hormonal contraceptives, and other seizure medications. This enzyme-boosting effect makes long-term barbiturate use complicated to manage.
Dependence and Withdrawal Risks
Physical dependence can develop within weeks of regular use. Barbiturate withdrawal is one of the few drug withdrawal syndromes that can be fatal, alongside alcohol and benzodiazepine withdrawal. Symptoms typically begin 12 to 16 hours after the last dose and peak within one to three days, though longer-acting barbiturates may delay the onset.
Early withdrawal symptoms include anxiety, restlessness, nausea, vomiting, and tremors. More severe cases can progress to seizures, dangerously fast heart rate, and drops in blood pressure. Abdominal cramps, involuntary muscle jerks, and extreme agitation are also common. Because of these risks, stopping barbiturates abruptly after regular use is dangerous. Tapering under medical supervision is standard practice.
Signs of Barbiturate Overdose
Barbiturate overdose depresses the central nervous system progressively. Early signs include drowsiness, slurred speech, impaired coordination, and difficulty thinking clearly. As toxicity worsens, breathing becomes dangerously shallow, consciousness fades, and coma can follow. Staggering and loss of balance are also characteristic. Long-term excessive use produces its own pattern of chronic symptoms: memory loss, irritability, decreased day-to-day functioning, and unpredictable changes in alertness.